Retailer & Marketplace · vs · Advertiser / Brand · Retailer & Marketplace
CVS Health vs Walgreens
Structured technology and market comparison · 2026
Direct Feature Comparison
CVS Health · vs · WalgreensIntegrated US pharmacy, insurance, care delivery and retail media company.
US pharmacy retailer delivering prescriptions, healthcare services, consumer goods and retail media.
Analyze all overlapping signals and tech stacks for CVS Health and Walgreens
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between CVS Health and Walgreens?
When comparing CVS Health and Walgreens, both platforms operate within the Retailer & Marketplace ecosystem. CVS Health is positioned as Integrated US pharmacy, insurance, care delivery and retail media company, whereas Walgreens focuses on US pharmacy retailer delivering prescriptions, healthcare services, consumer goods and retail media. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to CVS Health and Walgreens?
When evaluating CVS Health and Walgreens, enterprise buyers also consider other platforms in Retailer & Marketplace. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of CVS Health and Walgreens compare?
CVS Health is headquartered in United States (founding year unrecorded) with >5,000 employees. Walgreens is based in United States (founded in 1901) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: CVS Health vs Walgreens
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
CVS Health
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for CVS Health (2026-11-04)
On November 4, 2026, CVS Health Corporation furnished a Current Report on Form 8-K announcing its plan to execute a corporate breakup into two independent, publicly traded companies. Disclosed under Item 7.01 (Regulation FD Disclosure), the separation is intended to be structured as a tax-free spin-off for U.S. federal income tax purposes to the company and its shareholders. The transaction represents a structural pivot from CVS Health's integrated healthcare conglomerate model, designed to unlock shareholder value by creating distinct, standalone operating entities.
- CVS Health announced its intention on November 4, 2026, to separate into two independent, publicly traded companies.
- The transaction is intended to be structured as tax-free for U.S. federal income tax purposes for both the company and its shareholders.
- The announcement was furnished under Item 7.01 (Regulation FD Disclosure) accompanied by a press release filed as Exhibit 99.1.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for CVS Health (2026-11-04)
CVS Health Corporation reported consolidated revenues of $108.40 billion for Q3 2026, representing a 5.4% year-over-year increase driven by volume and pricing expansion across Health Services and Health Care Benefits. Operating income rebounded sharply to $3.57 billion compared to an operating loss of $3.21 billion in Q3 2025, primarily due to the absence of a prior-year $5.73 billion goodwill impairment in Health Care Delivery and improved medical loss ratio performance in Health Care Benefits (MBR decreased 150 bps to 91.3%). Net income attributable to CVS Health reached $2.17 billion ($1.68 diluted EPS), supported by strong nine-month operating cash flow of $15.32 billion. Concurrently, CVS announced a definitive plan to separate into two independent publicly traded entities by H1 2028: a healthcare solutions entity (encompassing Aetna, Caremark, CVS Specialty, Oak Street Health, and Signify Health) and a standalone retail pharmacy and community care business (CVS Pharmacy).
- Q3 2026 consolidated revenue rose 5.4% year-over-year to $108.40B, and operating income reached $3.57B against an operating loss of $3.21B in Q3 2025.
- Health Care Benefits MBR improved by 150 bps to 91.3% in Q3 2026, with segment adjusted operating income surging 190.4% to $912M.
- Announced a planned tax-free corporate separation into two independent publicly traded companies (healthcare solutions vs. retail pharmacy/community healthcare) targeted for completion in H1 2028.
- ·CNBC InvestingFinancials
Goldman recommends defensive stocks amid AI bull concerns
Goldman Sachs advises investors concerned about a potential slowdown in the AI trade to consider defensive stocks in health care and consumer staples. The bank notes that AI capital spending currently contributes about half of S&P 500 earnings growth, but expects this to diminish as spending growth slows. Rising energy prices and interest rates are clouding the economic outlook, with higher financing costs raising doubts about the durability of the AI infrastructure buildout. Goldman's screen highlights companies with high free cash flow yields and recent underperformance, such as Tyson Foods (11% FCF yield, down 17% over six months) and CVS Health (9% FCF yield, down 15% in three months). Despite these defensive recommendations, Goldman's base case still expects continued earnings growth, with a potential catch-up trade in consumer-facing stocks fueled by weaker energy prices and falling interest rates anticipated in 2027.
- Goldman Sachs recommends defensive stocks in health care and consumer staples amid AI trade concerns.
- AI capital spending contributes about half of S&P 500 earnings growth, but Goldman expects this to diminish.
- Rising energy prices and interest rates are clouding the economic outlook.
Walgreens
Recent Signals
- ·The DrumRetail Media
Retail media networks shift focus back to onsite ads
A new survey of 61 US retail media network (RMN) leaders by eMarketer and Bain & Company reveals a strategic retreat from offsite formats like social, CTV, and influencers back to onsite product advertising. The survey, conducted in July, found that the top three growth formats for the next year are all onsite: search and sponsored product ads (43%), native AI ads (39%), and display/banner ads (36%). This shift is driven by higher profit margins (70-80% onsite vs. 40% offsite), greater control, and fewer third parties involved. Offsite expansion, including social and in-store, has proven difficult to sell, with social retail media spending under 2% of total US retail media spend. However, the strategy carries risks, as AI assistants could bypass retailer-owned purchase journeys, threatening the sponsored listings that dominate onsite revenue. Only a few well-resourced networks like Best Buy are pursuing big offsite bets.
- Survey of 61 US retail media network leaders conducted in July shows top growth formats for next year are all onsite.
- Onsite advertising generates profit margins of around 70-80% for US retailers, compared to roughly 40% for offsite.
- Retail media spending on social will be about $1.3bn in the US this year, under 2% of total retail media spend.
- ·Modern RetailRetail Media
Walgreens Partners with Looma for In-Store Digital Screens
Walgreens announced a partnership with in-store media firm Looma to deploy digital screens in 1,200 stores starting October, aiming to strengthen its retail media business. The screens, placed near products, will feature advertising and educational content. This initiative follows a previous failed attempt with Cooler Screens, which involved a $200 million dispute. Walgreens emphasizes higher-performing placements and full-funnel metrics. The partnership extends Looma's network, which already includes retailers like Kroger and H-E-B. Industry experts note the potential of pharmacy areas for high dwell-time advertising. Competitor CVS has also been expanding its digital screen presence.
- Walgreens will add digital screens in 1,200 stores starting October.
- Partnership with Looma, which has over 7,000 screens across 10 banners.
- Previous Cooler Screens partnership ended in a $200 million dispute.
- ·The DrumRetail / Physical Stores
Store Closures Can Strengthen Brands, Not Just Signal Retreat
Major retailers including Petsense, Walgreens and others announced store closures in early 2026, with more than 3,300 US stores closed or earmarked for closure in H1 2026. Experts quoted in the article argue that closures can reflect business optimisation rather than systemic decline: cutting unprofitable locations while investing in stronger sites can improve brand health and visibility. The piece contrasts examples such as Tractor Supply closing many Petsense locations while opening namesake stores, Starbucks closing weaker sites but renovating and opening others, and Wayfair expanding into physical stores after heavy digital marketing spend. The analysis concludes that context matters: closures driven by restructuring can be sensible pruning, whereas closures driven by debt and collapsing demand indicate deeper business problems.
- More than 3,300 US stores closed or were earmarked for closure in the first half of 2026.
- The 3,300 figure was 44% lower than the same period in the previous year.
- Tractor Supply decided to close 75 Petsense stores, described as more than a third of Petsense locations, citing negative four-wall cash flow.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners CVS Health and Walgreens share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks